These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 24180408)
1. Current and future insights in H. pylori eradication regimens: the need of tailoring therapy. Papastergiou V; Georgopoulos SD; Karatapanis S Curr Pharm Des; 2014; 20(28):4521-32. PubMed ID: 24180408 [TBL] [Abstract][Full Text] [Related]
2. Importance of antimicrobial susceptibility testing for the management of eradication in Arslan N; Yılmaz Ö; Demiray-Gürbüz E World J Gastroenterol; 2017 Apr; 23(16):2854-2869. PubMed ID: 28522904 [TBL] [Abstract][Full Text] [Related]
3. Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Nijevitch AA; Idrisov B; Akhmadeeva EN; Graham DY Curr Pharm Des; 2014; 20(28):4510-6. PubMed ID: 24180406 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance. Papastergiou V; Georgopoulos SD; Karatapanis S World J Gastroenterol; 2014 Aug; 20(29):9898-911. PubMed ID: 25110420 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Helicobacter pylori infection: Past, present and future. Papastergiou V; Georgopoulos SD; Karatapanis S World J Gastrointest Pathophysiol; 2014 Nov; 5(4):392-9. PubMed ID: 25400982 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori: future perspectives in therapy reflecting three decades of experience. Kanizaj TF; Kunac N World J Gastroenterol; 2014 Jan; 20(3):699-705. PubMed ID: 24574743 [TBL] [Abstract][Full Text] [Related]
12. Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country? Almeida N; Donato MM; Romãozinho JM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Fernandes A; Calhau C; Sofia C BMC Gastroenterol; 2015 Feb; 15():23. PubMed ID: 25886722 [TBL] [Abstract][Full Text] [Related]
13. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Miftahussurur M; Yamaoka Y Molecules; 2015 Apr; 20(4):6068-92. PubMed ID: 25856059 [TBL] [Abstract][Full Text] [Related]
14. Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. Heo J; Jeon SW World J Gastroenterol; 2014 May; 20(19):5654-9. PubMed ID: 24914324 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori: management in 2013. Alahdab YO; Kalayci C World J Gastroenterol; 2014 May; 20(18):5302-7. PubMed ID: 24833860 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Helicobacter pylori infection: current status and future concepts. Yang JC; Lu CW; Lin CJ World J Gastroenterol; 2014 May; 20(18):5283-93. PubMed ID: 24833858 [TBL] [Abstract][Full Text] [Related]
17. Attempts to enhance the eradication rate of Helicobacter pylori infection. Bang CS; Baik GH World J Gastroenterol; 2014 May; 20(18):5252-62. PubMed ID: 24833855 [TBL] [Abstract][Full Text] [Related]
18. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies. Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773 [TBL] [Abstract][Full Text] [Related]
19. Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial. Heo J; Jeon SW; Jung JT; Kwon JG; Lee DW; Kim HS; Yang CH; Park JB; Park KS; Cho KB; Lee SH; Jang BI; J Gastroenterol Hepatol; 2015 Sep; 30(9):1361-6. PubMed ID: 25867608 [TBL] [Abstract][Full Text] [Related]